Oncology and Hematology

785-790 of 790

• 

  RestartResume

  Improving the Prognoses of Multiple Myeloma

  RestartResume

  Improving the Prognoses of Multiple Myeloma

  Clinician's Roundtable

  Improving the Prognoses of Multiple Myeloma

  Mark Nolan Hill, MD; James Berenson, MD

  • 

    

    Mark Nolan Hill, MD

  • 

    

    James Berenson, MD

• 

  RestartResume

  Multiple Myeloma: Current Treatment Modalities

  RestartResume

  Multiple Myeloma: Current Treatment Modalities

  Clinician's Roundtable

  Multiple Myeloma: Current Treatment Modalities

  Mark Nolan Hill, MD; James Berenson, MD

  • 

    

    Mark Nolan Hill, MD

  • 

    

    James Berenson, MD

• 

  RestartResume

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  RestartResume

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  Clinician's Roundtable

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  Bill Rutenberg, MD; Andrew Vickers, PhD

  • 

    

    Bill Rutenberg, MD

  • 

    

    Andrew Vickers, PhD

• 

  RestartResume

  The Environmental Etiologies of Multiple Myeloma

  RestartResume

  The Environmental Etiologies of Multiple Myeloma

  Clinician's Roundtable

  The Environmental Etiologies of Multiple Myeloma

  Shira Johnson, MD; Brian Durie, MD

  • 

    

    Shira Johnson, MD

  • 

    

    Brian Durie, MD

• 

  RestartResume

  New Treatments for Multiple Myeloma

  RestartResume

  New Treatments for Multiple Myeloma

  Clinician's Roundtable

  New Treatments for Multiple Myeloma

  Shira Johnson, MD; Brian Durie, MD

  • 

    

    Shira Johnson, MD

  • 

    

    Brian Durie, MD

• 

  RestartResume

  Endometrial Cancer

  RestartResume

  Endometrial Cancer

  Clinician's Roundtable

  Endometrial Cancer

  Joel Heller, MD; Diljeet Singh, MD

  • 

    

    Joel Heller, MD

  • 

    

    Diljeet Singh, MD

• Previous
• 1
• 2
• …
• 48
• 49
• 50
• Next